Please ensure Javascript is enabled for purposes of website accessibility

Why Exact Sciences, Align Technology, and ShockWave Medical Shares Are Plunging Today

By Brian Feroldi - Mar 12, 2020 at 1:02PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

We're officially in a bear market.

What happened

Shares of Exact Sciences (EXAS -2.93%), Align Technology (ALGN -2.26%), and ShockWave Medical (SWAV -1.65%) all dropped by double digits in early-morning trading on Thursday. As of 11:53 a.m. EDT, these healthcare stocks were down 7%, 9%, and 13%, respectively. 

So what

The declines do not appear to be linked to anything that the companies themselves have done. There were no press releases issued today, and none of these businesses filed anything with the SEC. No Wall Street analysts hit these companies with a downgrade, either.

That makes it likely that these growth stocks are simply being dragged down by another day of huge declines in the markets. The S&P 500, Dow Jones Industrial, and Nasdaq all dropped at least 5% in early-morning trading over the growing panic related to the spread of the novel coronavirus.

Man in suit holding a smal bear statue

Image source: Getty Images.

As of Wednesday, the Dow officially crossed into bear market territory. If these early-morning losses hold, the S&P 500 and Nasdaq could soon be there, too.

Now what

Exact Sciences, Align Technology, and ShockWave Medical are all growth stocks that investors awarded high valuations in the very recent past. During bear markets, growth stocks tend to fall at a faster rate than the overall market, so it isn't surprising to see that these stocks are declining so rapidly today.

While there's no telling where the companies' stocks might be headed next, investors do have a good idea of what these businesses hope to accomplish in 2020.

In 2019, Exact Sciences grew its revenue by 93% to $876 million, which is a stellar performance. Part of that growth was driven by last year's acquisition of Genomic Health, but the company's flagship Cologuard testing product is also growing quickly. For the full year of 2020, management is guiding for revenue to land between $1.61 billion and $1.645 billion, which represents growth of 86%. That's a number that should please any growth-focused investor.  

Align Technology also had a prosperous 2019. Sales grew 22% to $2.4 billion thanks to strong demand for its Invisalign retainer system, and EPS expanded 12%. Align's management doesn't give full-year guidance, but it did call for revenue to grow at least 12% in the first quarter of 2020. This business is highly profitable and still has plenty of room to run.

ShockWave Medical is the fastest-growing company of the three. Revenue soared 250% in 2019 to $42.9 million, a clear sign that demand for its intravascular lithotripsy (IVL) system is taking off. ShockWave guided for revenue to land between $74 million and $77 million in 2020, which would represent growth of 72% to 79%. I personally wouldn't be surprised to see the company do even better than that. 

It's impossible to predict when the novel coronavirus outbreak is going to come to an end, and it's just as hard to foretell when this bear market is going to bottom. However, if you still believe that these high-quality medical device companies can continue to grow for many years to come, you shouldn't let the recent volatility scare you out of owning them.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Align Technology, Inc. Stock Quote
Align Technology, Inc.
ALGN
$236.67 (-2.26%) $-5.48
Exact Sciences Corporation Stock Quote
Exact Sciences Corporation
EXAS
$39.39 (-2.93%) $-1.19
ShockWave Medical Stock Quote
ShockWave Medical
SWAV
$191.17 (-1.65%) $-3.20

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
317%
 
S&P 500 Returns
112%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/30/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.